ILIKOS Consulting Group and Jordan Center for Pharmaceutical Research announce strategic partnership

Cyprus-based ILIKOS Consulting Group and Jordan Center for Pharmaceutical Research (JCPR) have announced a strategic partnership to highlight significant advantages in designing and executing BE/BA studies in Jordan and advancing innovative clinical research across the country

According to a relevant press release, the aims of the partnership are to introduce the advantages of conducting BA/BE clinical studies in Jordan and expand patient access to promising new therapies.

As the timelines for developing new therapies or technologies grow longer and the competitive landscape becomes increasingly high-risk, exploring emerging regions offering high quality, digestible cost and effective recruitment is essential. For the generics industry, numerous cross-regional challenges have also emerged: evolving regulatory requirements, data standardisation, and cost pressures.

"With increasing global pressures on the generics industry, from regulatory shifts to rising development costs, it's critical to explore innovative and reliable solutions," said Mr. Elias Sayias, Founder and CEO of ILIKOS. "Jordan's strategic position, combined with JCPR's extensive expertise, offer a compelling value proposition for Sponsors navigating the challenges of modern drug development. Our goal is to support bridging cultural, regulatory, and operational gaps to deliver cost-effective, high-quality outcomes."

JCPR, a hub of excellence in generics research with decades of experience offers generics manufacturers a turnkey solution to overcome development bottlenecks and operational complexities. The center specialises in navigating regulatory frameworks, ensuring data standardisation, and providing unmatched recruitment capabilities across the region.

JCPR is the 1st established and accredited Clinical Research Organization (CRO) located in Amman-Jordan. It has been accredited by the JFDA, GCC, EMA, and trusted across the MENA USA, Asia and North African regions.

"Jordan Center for Pharmaceutical Research (JCPR) has been a cornerstone of clinical research excellence in the MENA region for over two decades. As a leading institution in BA/BE studies for the generics industry, JCPR is proud to be EMA-inspected and accredited by numerous regulatory bodies. We are also delighted to have expanded our footprint to Europe and to strongly establishing ourselves in the fields of first-in-human studies, medical device testing, and clinical trials. Our services now support partners worldwide, including taking the first steps toward entering the U.S. market. With a steadfast commitment to high-quality, regulatory-compliant research, innovation, and precision, JCPR continues to be a trusted partner in advancing safe and effective medicines & Medical devices." said Eng. Tareq T. Arafat, Head of Business Development of JCPR.